BCCIP 抗体 (PE)
Quick Overview for BCCIP 抗体 (PE) (ABIN2170552)
抗原
See all BCCIP 抗体适用
宿主
克隆类型
标记
应用范围
-
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human BCCIP/TOK1
-
亚型
- IgG
-
-
-
-
应用备注
-
FCM: (1:20-100)
Optimal working dilution should be determined by the investigator. -
说明
-
Exitation/Emission: 480,565nm/578nm
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 100 μg/mL BSA, 50 % glycerol and 0.09 % sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at 4 °C for 12 months.
-
-
- BCCIP (BRCA2 and CDKN1A Interacting Protein (BCCIP))
-
别名
- Bccip
-
背景
-
FunctionMay promote cell cycle arrest by enhancing the inhibition of CDK2 activity by CDKN1A. May be required for repair of DNA damage by homologous recombination in conjunction with BRCA2. May not be involved in non-homologous end joining.
Synonyms: bccip, BCCIP_HUMAN, BCCIPalpha, BCCIPbeta, BRCA2 and CDKN1A interacting protein, BRCA2 and CDKN1A-interacting protein, BRCA2 and Cip1/p21 interacting protein, Cdk inhibitor p21 binding protein, P21 and CDK associated protein 1, P21- and CDK-associated protein 1, Protein TOK-1, Protein TOK1, TOK 1, TOK 1alpha, TOK 1beta, TOK1. -
基因ID
- 56647
抗原
-